Ji Hyung Lee

Ji Hyung Lee

Auto-generated profile, based on publicly available information

Ji Hyung Lee

Chungbuk National University Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JJJoo Jungwon
Joo Jungwon
JLJi Hyung Lee
Ji Hyung Lee
CCChi-Hoon Choi
Chi-Hoon Choi
JLjeonghwan lee
jeonghwan lee

1 September 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
JLJi Hyung Lee
Ji Hyung Lee
GWGeun Hui Won
Geun Hui Won
SLSang-Ick Lee
Sang-Ick Lee
CSChul-Jin Shin
Chul-Jin Shin
JSJung-Woo Son
Jung-Woo Son
FIFor The Alzheimer'S Disease Neuroimaging Initiative
For The Alzheimer'S Disease Neuroimaging Initiative
Background: Growing evidence links cardiovascular health to Alzheimer's disease (AD). While elevated plasma homocysteine (Hcy) is associated with cognitive decline, the relationship between cerebrospinal fluid (CSF) Hcy and the core pathological biomarkers of AD remains unclear. Objective: This study aimed to investigate the associations of CSF Hcy and plasma Hcy with CSF amyloid-β (Aβ 42 ), phosphorylated tau (p-tau), and total tau (t-tau). Methods: A total of 294 non-demented participants (110 cognitively normal, 184 with mild cognitive impairment) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were analyzed. Multivariate linear regression was used to analyze the relationships between CSF and plasma Hcy levels and CSF Aβ 42 , phosphorylated tau (p-tau), and total tau (t-tau). Logistic regression analyses assessed the association between Hcy levels and Aβ 42 positivity, tau positivity, and neurodegeneration positivity. Results: CSF Hcy levels showed significant positive associations with CSF p-tau and t-tau, as well as tau and neurodegeneration positivity. In contrast, no significant association was found between CSF Hcy and Aβ 42 pathology. Notably, plasma Hcy was not associated with any AD-related biomarkers. Conclusions: CSF Hcy, rather than plasma Hcy, was associated with markers of tau pathology and neurodegeneration in non-demented older adults. These findings suggest that CSF Hcy may be more closely associated with tau-related pathological processes during the pre-dementia stages of AD. Further research is needed to explore the mechanisms underlying these associations.